Endotoxin was demonstrated not to act as an adjuvant in the primary antibody response in the Syrian hamster. Minimal adjuvant action was demonstrable in antibody formation to a second injection of bovine gamma globulin. The immunological status of the hamster towards the endotoxin did not alter this weak adjuvant action. It was confirmed that the antimitotic drug colchicine will act as an adjuvant in the primary antibody response to sheep red blood cells but not to bovine gamma globulin or endotoxin in the Syrian hamster.
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Bacterial endotoxin has been shown to be an adjuvant to antibody formation in several animal species. The exact mechanism by which endotoxin exerts this adjuvant action remains undefined, but evidence supports the hypothesis that endotoxin damages lymphoid cells and releases nucleic acids (4) which will then enhance antibody formation (7) .
In previous experiments, bacterial endotoxin was found incapable of causing a generalized Shwartzman reaction (GSR) in the Syrian hamster under a variety of conditions, and it was not immunogenic after a single injection into these animals (6) . Endotoxin was, however, toxic to hamsters as evidenced by huddling, conjunctivitis, and fetal death. Since there was no detectable natural antibody and no detectable primary antibody response to endotoxin, it was felt that the hamster provided a system for investigating the role of immunity to endotoxin on its ability to act as an adjuvant. In addition, since colchicine causes a disease in pregnant Syrian hamsters indistinguishable from the GSR (2) and has been shown to be a weak but definite adjuvant to antibody formation in the hamster (3), experiments were undertaken to study its role as an adjuvant to antibody formation in the Syrian hamster in this laboratory. The effect of immunity to endotoxin on its ability to act as an adjuvant was then investigated. Neither hamsters which had been immunized previously with endotoxin and would now respond with a rapid production of antibody nor hamsters with circulating antibody to endotoxin produced a detectable primary response to BGG given with endotoxin. Antibody titers on days 7, 14, and 21 were 0.
MATERIALS AND METHODS

Animals
Effect of endotoxin on the secondary immune response. Although Syrian hamsters do not form detectable antibody to a single injection of BGG, they do form high titers of antibody after a second injection of the antigen. Accordingly, experiments were undertaken to test the effect of endotoxin given (i) with the antigen in the first injection, (ii) with the antigen in the second injection, and (iii) with both the first and second injections of antigen. The data recorded in Table 3 (4) , had been shown to act as an adjuvant to antibody formation in hamsters (5) . It seemed wise to document this adjuvant action in hamsters which were refractory to the effects of endotoxin. As can be seen from the data in Table 5 , there was a slight adjuvant action of colchicine on antibody formation to SRBC in these hamsters. The adju- 
